Janus Henderson Group PLC Uro Gen Pharma Ltd. Transaction History
Janus Henderson Group PLC
- $188 Billion
- Q4 2024
A detailed history of Janus Henderson Group PLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Janus Henderson Group PLC holds 14,000 shares of URGN stock, worth $157,080. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,000Holding current value
$157,080% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding URGN
# of Institutions
136Shares Held
36MCall Options Held
57.7KPut Options Held
9.8K-
Rtw Investments, LP New York, NY3.83MShares$43 Million0.67% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.93MShares$32.9 Million0.06% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$25.8 Million0.15% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$24.6 Million0.0% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A61.75MShares$19.6 Million0.03% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $255M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...